| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,209 |
3,335 |
$832K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,423 |
2,749 |
$759K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,378 |
921 |
$610K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,167 |
1,861 |
$425K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,446 |
3,760 |
$420K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,057 |
1,548 |
$169K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,309 |
1,111 |
$84K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,096 |
1,757 |
$74K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,789 |
1,214 |
$72K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
326 |
279 |
$56K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
751 |
637 |
$53K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,257 |
1,540 |
$45K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
563 |
478 |
$44K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
390 |
338 |
$40K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,140 |
4,004 |
$26K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
106 |
63 |
$25K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
493 |
353 |
$23K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,061 |
355 |
$22K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
502 |
131 |
$21K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
680 |
542 |
$20K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,337 |
455 |
$19K |
| 71046 |
Radiologic examination, chest; 2 views |
1,063 |
810 |
$19K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,525 |
1,288 |
$19K |
| 80051 |
|
3,773 |
2,810 |
$19K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
808 |
270 |
$16K |
| 70450 |
Computed tomography, head or brain; without contrast material |
49 |
42 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,072 |
896 |
$15K |
| 82565 |
|
4,750 |
3,624 |
$15K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
57 |
49 |
$13K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,762 |
1,373 |
$12K |
| 80061 |
Lipid panel |
948 |
804 |
$11K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,394 |
1,045 |
$10K |
| 84460 |
|
2,734 |
2,220 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
959 |
823 |
$8K |
| 82947 |
|
3,050 |
2,545 |
$8K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
458 |
388 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
4,414 |
3,299 |
$6K |
| 84450 |
|
1,808 |
1,494 |
$6K |
| 81001 |
|
2,200 |
1,822 |
$6K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
16 |
12 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
493 |
382 |
$5K |
| 84075 |
|
1,816 |
1,489 |
$5K |
| 84520 |
|
2,668 |
2,146 |
$5K |
| 82247 |
|
2,025 |
1,602 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
83 |
69 |
$5K |
| 85027 |
|
908 |
659 |
$5K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
142 |
114 |
$5K |
| 87081 |
|
419 |
358 |
$4K |
| 83690 |
|
680 |
568 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
246 |
186 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
534 |
449 |
$2K |
| A0380 |
Bls mileage (per mile) |
159 |
78 |
$2K |
| 81025 |
|
243 |
224 |
$2K |
| 82040 |
|
575 |
472 |
$2K |
| 84484 |
|
447 |
244 |
$2K |
| 85610 |
|
645 |
335 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
565 |
422 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
372 |
294 |
$1K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
89 |
45 |
$1K |
| 83605 |
|
310 |
234 |
$1K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
31 |
24 |
$1K |
| 90686 |
|
50 |
47 |
$991.41 |
| 81003 |
|
481 |
419 |
$939.14 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
240 |
190 |
$866.79 |
| 84132 |
|
186 |
148 |
$683.18 |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
97 |
79 |
$489.47 |
| 82310 |
|
168 |
142 |
$426.78 |
| 90656 |
|
19 |
19 |
$396.04 |
| 83735 |
|
113 |
95 |
$347.92 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
14 |
13 |
$305.90 |
| 84145 |
|
41 |
36 |
$304.99 |
| 3008F |
|
29 |
27 |
$260.00 |
| 87077 |
|
69 |
50 |
$248.40 |
| G0378 |
Hospital observation service, per hour |
25 |
12 |
$226.25 |
| 86140 |
|
47 |
37 |
$187.05 |
| 80053 |
Comprehensive metabolic panel |
46 |
40 |
$185.47 |
| 82728 |
|
17 |
12 |
$126.72 |
| 82962 |
|
63 |
37 |
$114.80 |
| 82077 |
|
16 |
13 |
$110.56 |
| J7050 |
Infusion, normal saline solution, 250 cc |
833 |
567 |
$99.68 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,999 |
1,339 |
$80.70 |
| 87186 |
|
18 |
13 |
$71.52 |
| A9270 |
Non-covered item or service |
5,447 |
1,036 |
$56.23 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
109 |
101 |
$30.19 |
| 85018 |
|
14 |
13 |
$24.50 |
| 87040 |
|
27 |
12 |
$21.32 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
52 |
38 |
$10.49 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
494 |
255 |
$9.66 |
| J3490 |
Unclassified drugs |
104 |
82 |
$7.69 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
208 |
93 |
$6.34 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
142 |
108 |
$2.44 |
| A0425 |
Ground mileage, per statute mile |
33 |
26 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
41 |
38 |
$0.00 |